Prognostic significance of IgG-Kappa positivity detected by serum immunofixation during daratumumab therapy in multiple myeloma. [PDF]
Cengiz E +3 more
europepmc +1 more source
T-cell-redirecting therapies in early relapsed multiple myeloma: a systematic review and network meta-analysis. [PDF]
Merz M +14 more
europepmc +1 more source
Repeated Response to Daratumumab in Refractory MGUS-Associated Pure Red Cell Aplasia Persisting After Allogeneic Transplantation: A Case Report. [PDF]
Yoshihara K +9 more
europepmc +1 more source
CBP per cumulative indication for daratumumab and pembrolizumab per vial.
CBP per cumulative indication for daratumumab and pembrolizumab per vial.
C. A. Uyl-de Groot (4039742) +5 more
core +1 more source
Infectious Complications and Toxicities of the Teclistamab Plus Daratumumab Combination in Relapsed or Refractory Multiple Myeloma: A Disproportionality and Drug-Interaction Analysis of the FDA Adverse Event Reporting System. [PDF]
Awadallah C +3 more
europepmc +1 more source
Rescue therapy of paediatric lupus nephritis with plasma cell-directed antibodies. [PDF]
Kasinathan S +14 more
europepmc +1 more source
CD38-targeted therapies in kidney disease: evidence maturity, disease-stage dependence, and biomarker-guided retreatment. [PDF]
Feng P, Yu X.
europepmc +1 more source
An Ex Vivo 3D Co-Culture Model of the Bone Marrow Niche Better Predicts Clinically Relevant Epigenetic Target Modulation to Improve Immunotherapy in Multiple Myeloma. [PDF]
Greil C +5 more
europepmc +1 more source
Effects of Daratumumab Treatment on a Case of Overlapping Autoimmunity With Sjögren's Disease and Linear IgA Dermatosis. [PDF]
Hut C +7 more
europepmc +1 more source
Efficacy and safety of daratumumab-based quadruplet therapy vs non-daratumumab-based triplet therapy in newly diagnosed multiple myeloma patients: A GRADE assessed systematic review and meta-analysis of randomized controlled trials. [PDF]
Osama M +13 more
europepmc +1 more source

